Investigational Drugs List
Groups Distribution
Phase Distribution
Filter Conditions
Investigational Drugs List
| Drugs ID | CID | Drugs | Identifier | Molecular Formula | Molecular Weight | Groups | US Approved | Details |
|---|---|---|---|---|---|---|---|---|
| Drug111 | 9887712 | Dapagliflozin | NCT05986136 | C21H25ClO6 | 408.90 | approved | YES | Details |
| Drug112 | 9926791 | Tofacitinib | NCT00787202, NCT03281304, NCT01458574, NCT01470612, NCT06625450, NCT04424303, NCT05112263, NCT06095128, NCT05728008, NCT05431283, NCT05313620, NCT04925973, NCT06780683, NCT06274996, NCT05782907, NCT06095596, NCT03653026, NCT02819635, NCT03345836, NCT03006 | C16H20N6O | 312.37 | approved | YES | Details |
| Drug113 | 10034073 | Fidaxomicin | NCT06794944 | C52H74Cl2O18 | 1058.00 | approved | YES | Details |
| Drug114 | 10174505 | XELJANZ | NCT00152841 | C22H28N6O8 | 504.50 | NULL | NULL | Details |
| Drug115 | 10182969 | Apixaban | NCT03935451 | C25H25N5O4 | 459.50 | approved | YES | Details |
| Drug116 | 10296883 | Sotrastaurin | NCT00572585 | C25H22N6O2 | 438.50 | NULL | NULL | Details |
| Drug117 | 10343454 | Vercirnon | NCT01658605 | C22H21ClN2O4S | 444.90 | NULL | NULL | Details |
| Drug118 | 10479502 | Elubrixin | NCT00748410 | C17H17Cl2FN4O4S | 463.30 | NULL | NULL | Details |
| Drug119 | 11155873 | Mocravimod | NCT01375179 | C24H27Cl2NO3S | 480.40 | NULL | NULL | Details |
| Drug120 | 11547499 | CE-224535 | NULL | C22H29ClN4O6 | 480.90 | NULL | NULL | Details |